CohBar, Inc. (NASDAQ:CWBR – Get Free Report)’s stock price shot up 11.6% during mid-day trading on Wednesday . The company traded as high as $0.49 and last traded at $0.48. 5,496 shares traded hands during trading, an increase of 123% from the average session volume of 2,462 shares. The stock had previously closed at $0.43.
CohBar Stock Performance
The business’s 50 day simple moving average is $0.40 and its 200-day simple moving average is $0.63. The company has a market cap of $1.40 million, a price-to-earnings ratio of -0.11 and a beta of 1.40.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
Featured Articles
- Five stocks we like better than CohBar
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is a support level?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Trading Halts Explained
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.